22 Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Moleculin Biotech Inc MBRX shares rose 40.7 percent to $3.39 in the pre-market trading session after the company disclosed that it has received the FDA approval for its Annamycin IND.
• Ascena Retail Group Inc ASNA rose 16.6 percent to $2.53 in pre-market trading after the company posted stronger-than-expected results for its fourth quarter.
• Chromadex Corp CDXC rose 16 percent to $5.00 in pre-market trading after the company reported top-line results from its second human clinical trial.
• Greenhill & Co., Inc. GHL shares rose 13.9 percent to $16.40 in pre-market trading after the company disclosed outline of recap plan and share repurchase.
• Social Reality Inc SRAX shares rose 10.2 percent to $2.70 in pre-market trading after surging 50.31 percent on Monday.
• Vascular Biogenics Ltd VBLT rose 9.3 percent to $7.10 in pre-market trading after gaining 4.84 percent on Monday.
• Apollo Endosurgery Inc APEN rose 7.7 percent to $4.90 in pre-market trading after falling 0.87 percent on Monday.
• ProQR Therapeutics NV PRQR rose 7 percent to $6.90 in pre-market trading after the company disclosed 'positive' top-line data from Phase 1b study of QR-010.
• Izea Inc IZEA rose 6.8 percent to $5.18 in pre-market trading after jumping 51.56 percent on Monday.
• Akebia Therapeutics Inc AKBA rose 5.1 percent to $18.80 in pre-market trading. Akebia Therapeutics disclosed that statistically significant improvements in the primary endpoint were made in its Phase 2 study of Vadadustat.
• Helios and Matheson Analytics Inc HMNY rose 4.6 percent to $8.68 in pre-market trading after surging 19.08 percent on Monday.
• Red Hat Inc RHT rose 4.3 percent to $110.26 in pre-market trading after the company reported better-than-expected results for its second quarter and raised its guidance for the year.
• Kitov Pharmaceuticals Holdings Ltd (ADR) KTOV shares rose 3.7 percent to $2.22 in pre-market trading after climbing 12.63 percent on Monday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Axovant Sciences Ltd AXON shares fell 69.7 percent to $7.36 after the company disclosed that Phase 3 MINDSET clinical trial did not meet its co-primary efficacy endpoints.
• Genocea Biosciences Inc GNCA fell 55.2 percent to $2.39 in pre-market trading after the company reported strategic shift to immuno-oncology and development of neoantigen cancer vaccines. The company also announced plans to explore strategic alternatives for GEN-003 and lower staff by 40 percent.
• Kadmon Holdings Inc KDMN fell 21.1 percent to $2.99 in pre-market trading as the company reported mixed shelf offering.
• QEP Resources Inc QEP shares fell 7.1 percent to $8.25 in pre-market trading after the company reported the closing of Pinedale asset sale and lowered its FY17 production outlook.
• TherapeuticsMD Inc TXMD shares fell 6.8 percent to $5.65 in pre-market trading. TherapeuticsMD priced its 12.4 million share offering at $5.65 per share.
• Sabra Health Care REIT Inc SBRA fell 6.1 percent to $20.98 in pre-market trading. Sabra Health Care REIT priced an underwritten public offering of 16,000,000 shares at $21.00 per share.
• Aradigm Corporation ARDM shares fell 5.1 percent to $3.19 in pre-market trading after climbing 32.81 percent on Monday.
• Cheesecake Factory Inc CAKE fell 4.6 percent to $39.70 in pre-market trading. Wedbush downgraded Cheesecake Factory from Outperform to Neutral.
• Darden Restaurants, Inc. DRI shares fell 3.8 percent to $80.02 in pre-market trading. Darden posted in-line quarterly earnings.